PALATIN TECHNOLOGIES Forum: Community User: CologneFC

Wollte bei 0,45€ nachkaufen... :D

EK leider noch bei 1,00€

Auf jeden Fall eine überraschende Meldung hier. Hoffentlich mit Substanz.

Das wäre schön...

Ja es tut weh, ich hoffe auf ein Wunder. Wobei ich nicht im Minus bin, aber viel Gewinn verloren. Immerhin etwas gelernt. Vielleicht zieht Palatin unsere Depots wieder hoch.

Krass... Palatin... Na da bin ich mal gespannt wie der kurs sich entwickelt...

@RainKing... Wirecard tut richtig weh... -80% ...aber heute +40% :)

Medikament gegen Corona

CRANBURY, N.J., June 23, 2020 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced it is developing PL8177 as a treatment for patients with COVID-19, the disease caused by infection with the SARS-CoV-2 virus, and having hypoxemic respiratory failure with or without acute respiratory distress syndrome (ARDS). This decision was based on positive results in preclinical multiple inflammatory disease models and a lung injury model, which showed the ability of PL8177 to reduce inflammation, protect lung tissue and reduce lung fibrosis. Palatin Technologies, Inc. Palatin submitted a preliminary proposal to the Biomedical Advanced Research and Development Authority (BARDA) on this program, received technical and strategic advice, and submitted a pre-Investigational New Drug (pre-IND) package to the Division of Pulmonary, Allergy, and Critical Care (DPACC) of the U.S. Food and Drug Administration (FDA). Based on advice from DPACC the Company is planning to submit an IND in the third quarter of calendar year 2020 and planning a Phase 2 clinical trial initiation in the fourth quarter of calendar year 2020. Required preclinical and Phase 1 safety studies are complete and *** the safe use of PL8177 in a Phase 2 clinical study. In addition, Palatin is pursuing multiple sources for research and development grants to *** PL8177 clinical development.

Hammer...

Habe ich was verpasst?

Tut gut, neben der Wirecard im Depot 😂

Oh

Weiss jemand was???

Schade luck

Wollte noch kaufen...